AMENDED AND RESTATED REGISTRATION RIGHTS AND LOCK-UP AGREEMENT by and among OCULIS HOLDING AG and THE SHAREHOLDERS THAT ARE SIGNATORIES HERETO Dated as of 2 March, 2023Joinder Agreement • March 8th, 2023 • Oculis Holding AG • Pharmaceutical preparations • New York
AMENDED AND RESTATED REGISTRATION RIGHTS AND LOCK-UP AGREEMENT, dated as of 2 March 2023 (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), is made and entered into by and among (i) Oculis Holding AG, a stock corporation (Aktiengesellschaft) incorporated and existing under the laws of Switzerland (the “Company”), (ii) the shareholders of the Company party hereto, as listed on Schedule 1 attached hereto (the “Shareholders”) and (iii) any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.6 of this Agreement (each, a “Holder” and collectively with the Shareholders, the “Holders”).
WARRANT ASSIGNMENT AND ASSUMPTION AGREEMENTWarrant Assignment and Assumption Agreement • March 8th, 2023 • Oculis Holding AG • Pharmaceutical preparations • New York
This Warrant Assignment and Assumption Agreement (this “Agreement”) is entered into as of 1 March, 2023, by and among European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), Oculis Holding AG, a stock corporation (Aktiengesellschaft) incorporated and existing under the laws of Switzerland (“New Parent”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
INDEMNIFICATION AGREEMENT by and amongIndemnification Agreement • March 8th, 2023 • Oculis Holding AG • Pharmaceutical preparations
The Company is a Swiss corporation registered with the commercial register of the Canton of Zug under the company identification number CHE-396.695.611.
